Literature DB >> 18034426

Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus.

Louise Jones1, Antony P Black, Gathsaurie N Malavige, Graham S Ogg.   

Abstract

Open reading frame 63 of varicella-zoster Virus (VZV) encodes an immediate early (IE) phosphoprotein (IE63) that is believed to be important for viral infectivity and establishing latency. Evidence suggests that VZV-specific T cells are crucial in the control of viral replication; however, data addressing the existence of IE63 protein-specific CD4+ T cells are limited. Using IFN-gamma immunosorbent assays, we identified high frequencies of responses to overlapping peptides spanning the IE63 protein both ex vivo and after in vitro restimulation in healthy VZV-seropositive individuals. We identified a commonly recognised epitope, restricted by HLA-DRB1*1501, which was naturally processed and presented by keratinocytes. We proceeded to investigate the frequency and phenotype of the epitope-specific CD4+ T cells using HLA class II tetrameric complexes. Epitope-specific CD4+ T cells were detectable ex vivo and showed a mixed central and effector-memory differentiation phenotype, with a significant proportion showing evidence of recent activation and rapid effector function. In summary these data implicate persistent low-level or recurrent VZV antigen exposure in healthy immune donors and are compatible with a role for IE63-specific CD4+ T cells in the control of viral reactivation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18034426     DOI: 10.1002/eji.200737648

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation.

Authors:  Insaf Salem Fourati; Anne-Julie Grenier; Élyse Jolette; Natacha Merindol; Philippe Ovetchkine; Hugo Soudeyns
Journal:  J Vis Exp       Date:  2014-07-09       Impact factor: 1.355

2.  Perspectives on vaccines against varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.

Authors:  Ryu Watanabe; Tsuyoshi Shirai; Hong Namkoong; Hui Zhang; Gerald J Berry; Barbara B Wallis; Benedikt Schaefgen; David G Harrison; Jennifer A Tremmel; John C Giacomini; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

4.  Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.

Authors:  Adriana Weinberg; Jennifer Canniff; Nadine Rouphael; Aneesh Mehta; Mark Mulligan; Jennifer A Whitaker; Myron J Levin
Journal:  J Immunol       Date:  2017-06-12       Impact factor: 5.422

5.  Tracking antigen-specific T-cells during clinical tolerance induction in humans.

Authors:  Aamir Aslam; Hsien Chan; David A Warrell; Siraj Misbah; Graham S Ogg
Journal:  PLoS One       Date:  2010-06-09       Impact factor: 3.240

6.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

7.  Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.

Authors:  G N Malavige; L Jones; A P Black; G S Ogg
Journal:  Clin Exp Immunol       Date:  2008-03-20       Impact factor: 4.330

8.  Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination.

Authors:  Qian Qi; Mary M Cavanagh; Sabine Le Saux; Hong NamKoong; Chulwoo Kim; Emerson Turgano; Yi Liu; Chen Wang; Sally Mackey; Gary E Swan; Cornelia L Dekker; Richard A Olshen; Scott D Boyd; Cornelia M Weyand; Lu Tian; Jörg J Goronzy
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

Review 9.  T-cell immunity to human alphaherpesviruses.

Authors:  Werner J D Ouwendijk; Kerry J Laing; Georges M G M Verjans; David M Koelle
Journal:  Curr Opin Virol       Date:  2013-05-08       Impact factor: 7.090

10.  IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.

Authors:  G N Malavige; L T Rohanachandra; L Jones; L Crack; M Perera; N Fernando; D Guruge; G S Ogg
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.